HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Incomplete Reiter's syndrome following chemotherapy of acute myeloid leukaemia.

Abstract
Reiter's syndrome and other reactive arthritides have been described following infection with various organisms although they can occur in unusual circumstances without an obvious infectious precipitant. We have recently witnessed two attacks of reactive arthritis and keratoderma blenorrhagica occurring in an HLA B27 adult male following chemotherapy on two separate occasions with the same drugs for acute myeloid leukaemia. No attacks occurred before or following the cessation of these drugs. This supports the view that in Reiter's syndrome a common pathogenic pathway is triggered by an 'arthritogenic factor' which in this case appears to have been chemical.
AuthorsF Dharmasena, H Englert, D Catovsky, D A Galton, H C Drysdale
JournalPostgraduate medical journal (Postgrad Med J) Vol. 62 Issue 733 Pg. 1045-6 (Nov 1986) ISSN: 0032-5473 [Print] England
PMID3476917 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Cytarabine
  • Allopurinol
  • Thioguanine
  • Daunorubicin
Topics
  • Adult
  • Allopurinol (administration & dosage, adverse effects)
  • Antineoplastic Combined Chemotherapy Protocols (adverse effects)
  • Arthritis, Reactive (chemically induced)
  • Cytarabine (administration & dosage, adverse effects)
  • Daunorubicin (administration & dosage, adverse effects)
  • Humans
  • Leukemia, Myeloid, Acute (drug therapy)
  • Male
  • Thioguanine (administration & dosage, adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: